UNICEF and Gavi Secure Mosqivac Price Cut

UNICEF and Gavi agreed to cut the Mosqivac malaria vaccine price by 40% to €5.50 ($6.16) per dose. The procurement deal generates $50M in savings across a three-year window from 2027 through 2029. Lower immunization costs expand healthcare access in regions burdened by malaria transmission.